The Dolphin Neurostim being used for MPS therapies, is supported by sufficient evidence that the application of DC micro-currents has positive results for chronic pain and stress management, however support in literature of MPS application to C-Section scars for post surgical pain reduction, is lacking. In a recent study conducted by Dr. Kelly Armstrong, with help from another physical therapist (PT), the aim was to asses impact and longevity of MPS therapy when applied to C-Section scars. A sample of 47 patients was used in the study, gauging pain levels in the chronic pain patients, after a single application of MPS therapy.

The Visual Analogue Scale (generic one-dimensional pain questionnaire- VAS) was used in evaluating patients pain. The VAS is an 11-point scale from 0-10 with 0 being no pain and 10 being the most intense pain imaginable. Patients verbally selected the value the pertained to them most in the past 24 hours, or pain that was often reported during a specific movement pattern or functional task. Patient pain scores were then also taken immediately pre treatment and twice post treatment: once immediately after MPS application, and again 48 hours later.

Most scar management techniques tend to be invasively applied, such as corticosteroid injections, excisions, and neural therapies. MPS Scar Release Protocol however, is a patented process developed as a non-invasive alternate to such therapies. The protocol entails simultaneous application of two Dolphin Neurostim devices (Center for Pain and Stress Research Ltd, Ontario, Canada), across each side of the scar. This device is FDA-approved, applying low frequency, concentrated, DC- micro-current stimulation for the relief of chronic pain and stress. Application time for each point, at approximately one quarter (1/4) inch intervals along the length of the C-Section scars, lasted 30 seconds. The average duration time of the application of the Scar Release Protocol was 30 minutes per patient. The VAS response from the 47 patient sample, reflected a significant reduction in average post pain levels of 67.5% when compared to initial pain levels. At the 48 hour follow up, there was a further reduction of 45.2 percent, for a total pain reduction of 82.2 percent, in comparison to initial pain levels.